menu
    • menu

    Company profile for Avectas

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avectas is a cell engineering technology business, enabling the manufacture of cell therapies. Avectas’ technology, Solupore®, delivers advanced molecules such as mRNA, proteins and gene editing tools to a range of primary cell types including T cells for immuno-oncology and gene editing applications. Solupore® utilizes a membrane disruptive approach to rapidly deliver advanced molecules to cells. It is a simple, rapid and...
    Avectas is a cell engineering technology business, enabling the manufacture of cell therapies. Avectas’ technology, Solupore®, delivers advanced molecules such as mRNA, proteins and gene editing tools to a range of primary cell types including T cells for immuno-oncology and gene editing applications. Solupore® utilizes a membrane disruptive approach to rapidly deliver advanced molecules to cells. It is a simple, rapid and gentle process that yields superior engineered cells. Solupore® results in improved cell processing times and cell health relative to viral vectors and electroporation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AvectasUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 First Street, Suite 1800 Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avectas.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/avectas
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/avectas?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avectas Expands Collaboration with CCRM and OmniaBio Inc.
    Avectas Expands Collaboration with CCRM and OmniaBio Inc.

    29 Nov 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-11-29/avectas-expands-collaboration-with-ccrm-and-omniabio-inc/?widget=listSection

    CONTRACTPHARMA
    29 Nov 2022
    Share Share
    Inceptor Bio and Avectas partner for CAR-T cell therapies development
    Inceptor Bio and Avectas partner for CAR-T cell therapies development

    13 Oct 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/inceptor-bio-avectas-car-t-cell/

    PHARMACEUTICAL-TECHNOLOGY
    13 Oct 2022
    Share Share
    Inceptor, Avectas team up to tackle solid tumor CAR-Ts
    Inceptor, Avectas team up to tackle solid tumor CAR-Ts

    12 Oct 2022

    // Gabrielle Masson FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/inceptor-avectas-team-attempts-develop-solid-tumor-car-t-therapies

    Gabrielle Masson FIERCEBIOTECH
    12 Oct 2022
    Share Share
    GenScript & Avectas Partner to Develop Cell Therapy Manufacturing Process
    GenScript & Avectas Partner to Develop Cell Therapy Manufacturing Process

    21 Sep 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-09-21/genscript-avectas-partner-to-develop-improved-non-viral-cell-therapy-manufacturing-process/?widget=listSection

    CONTRACTPHARMA
    21 Sep 2022
    Share Share
    Avectas Completes Significant Series C Funding Bringing Total Invested $40M
    Avectas Completes Significant Series C Funding Bringing Total Invested $40M

    16 Apr 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avectas-completes-significant-series-c-funding-bringing-total-invested-equity-to-over-40-million-301041273.html

    PR NEWSWIRE
    16 Apr 2020
    Share Share
    Avectas’ cell engineering technology receives US patent
    Avectas’ cell engineering technology receives US patent

    09 Apr 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=122356&sid=2

    PHARMABIZ
    09 Apr 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Avectas and get a quotation

    Avectas is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of SOLUPORE SA SOLUTION bulk with DMF offered by Avectas

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search